News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
As part of its strategy for growth in the biopharmaceutical industry, Trelleborg Healthcare & Medical will make an investment of several million dollars in expanding its manufacturing facility and BioPharma Center of Excellence in Northborough,...
The U.S. Food and Drug Administration (FDA) has approved bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel: a one-time gene therapy custom-designed to treat the underlying genetic cause of beta thalassemia in adult and pediatric...
West Pharmaceutical Services has made an investment in Latch Medical, a Dublin-based company working on next-generation vaccine and biologics delivery technology.